Knight

The HFW Companies Lands Strategic Growth Partnership With Dallas-Based Civil Engineering Firm KFM

Retrieved on: 
Monday, April 8, 2024
Professional Services, Engineering, Architecture, Manufacturing, Construction & Property, Consulting, Growth, Partnership, Knight, KFM, HFW, AIA

The HFW Companies (HFW), an expanding professional services firm in the architecture and engineering (AE) industry, has finalized yet another new strategic growth partnership in 2024, this time with Dallas, Texas-based civil engineering firm KFM.

Key Points: 
  • The HFW Companies (HFW), an expanding professional services firm in the architecture and engineering (AE) industry, has finalized yet another new strategic growth partnership in 2024, this time with Dallas, Texas-based civil engineering firm KFM.
  • In addition to civil engineering, KFM offers land planning, landscape architecture, and due diligence services.
  • Even as HFW has invested in KFM, Knight said he also views the new partnership as an investment by KFM in HFW as well, thanks to the HFW Partner network.
  • “We’re excited to leverage this partnership to expand our opportunities for new growth here and across the network.”
    For more information about KFM and the new growth partnership with The HFW Companies, please contact Jim Knight, P.E., at 972.322.7990.

Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call

Retrieved on: 
Thursday, March 14, 2024
Knight, GUD, TSX

MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2023 financial results on Thursday, March 21, 2024 prior to market opening.

Key Points: 
  • MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2023 financial results on Thursday, March 21, 2024 prior to market opening.
  • Following the release, Knight will hold a conference call and audio webcast.
  • Knight cordially invites all interested parties to participate in this call.

Broadtree Portfolio Company Sayres Defense Acquires Global Systems Technologies, Continuing GovCon Expansion

Retrieved on: 
Friday, March 22, 2024
Department of Defence, Partner, Culture, GST, Intelligence, Lockheed, Knight, Research, Acquisition, Investment, United States Navy, Development, National security, Multimedia, JRAD, Management

WASHINGTON, March 22, 2024 /PRNewswire/ -- Sayres Defense, a leader in defense mission support services to the US Navy, Department of Defense, and broader National Security community has acquired Global Systems Technologies (GST).

Key Points: 
  • WASHINGTON, March 22, 2024 /PRNewswire/ -- Sayres Defense, a leader in defense mission support services to the US Navy, Department of Defense, and broader National Security community has acquired Global Systems Technologies (GST).
  • GST is a leading provider of test and evaluation services, model-based systems engineering, logistics, research and development to Defense and Homeland Security customers.
  • With this acquisition, GST becomes the third company in Broadtree Partners' GovCon platform, joining Sayres Defense and Joint Research and Development (JRAD).
  • Tim Reardon, current CEO of Sayres Defense, JRAD, and prior Lockheed Martin and Leidos senior executive, will lead the combined companies as CEO.

GBK Brand Bar Celebrated their 15th Annual Luxury Lounge prior to Oscars, Presented by Care A2+

Retrieved on: 
Tuesday, March 12, 2024
Storm, Caviar, Safe Haven, Love, Wilshire Grand Center, Safe haven, Beverly Wilshire Hotel, Biomedical Research, Weight loss, Transport, Interview, Invincible, Regenerative medicine, Turks and Caicos Islands, GE Lighting, Hexagon, White, Red, Scott Evans, GBK, Jewellery, Collective identity, CARE, Longevity, Mother, Knight, Menopause, Human, Savant syndrome, Luminex, Red White and Blue, Drink, Good luck, Short, Elemental, Killers, Travel, Doctor of Philosophy, Organic, Electronics, Music, Multimedia, Luxury

BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+. GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways. As always, there was an amazing selection of beverages & food to nibble on, as well as music from DJ Kara keeping the guests entertained from the moment they entered.

Key Points: 
  • BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+.
  • GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways.
  • Care A2+ donated product to a local women's shelter in the name of the celebrities present.
  • Any media inquiries and/or interview request, please contact Tad Hamilton of Mosaic Public Relations at: [email protected]
    This press release was issued through 24-7PressRelease.com.

Knight Therapeutics Announces Launch of Minjuvi® in Brazil

Retrieved on: 
Thursday, February 29, 2024
ANVISA, DCR, Knight Therapeutics, TSX, DLBCL, GUD, Therapy, Health, Non-Hodgkin lymphoma, Patient, ASCT, Lenalidomide, Knight, Resolution

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi® (tafasitamab) by its Brazilian affiliate, United Medical Ltda.

Key Points: 
  • MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi® (tafasitamab) by its Brazilian affiliate, United Medical Ltda.
  • Additionally, in October 2023, Knight received pricing approval for Minjuvi® from the Drugs Market Regulation Chamber (“CMED”).
  • “In line with Knight’s commitment to advancing healthcare in Latin America, we are excited to launch Minjuvi in Brazil, an innovative treatment option for addressing a current unmet medical need,” said Samira Sakhia, Knight Therapeutics President and CEO.
  • “Knight’s team in Brazil is thrilled to make Minjuvi® available to health care professionals and centers, improving DLBCL patient care in the country,” said Cristiane Coelho, Knight Therapeutics Brazil General Manager.

Knight Therapeutics Inc. Celebrates its First Decade of Success

Retrieved on: 
Wednesday, February 28, 2024
Latin Americans, Acquisition, Knight, Marketing, TSX, Growth, GUD, Pharmacovigilance, Patient, Pharmaceutical industry

MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of expansion and growth.

Key Points: 
  • MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of expansion and growth.
  • Knight has invested over $925 million to build its unique pan-American (ex US) platform of innovative and branded generic pharmaceuticals.
  • Today, Knight has over 700 talented employees operating in Canada and 10 Latin American markets.
  • Since the completion of the acquisition of Biotoscana, Knight has entered into 11 new partnerships for 13 innovative and branded generic products.

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

Retrieved on: 
Wednesday, February 21, 2024
ANVISA, Fostamatinib, TSX, ITP, GUD, SYK, Therapy, Thrombocytopenia, Patient, Knight, Pharmaceutical industry

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health regulatory agency, for fostamatinib for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.

Key Points: 
  • MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health regulatory agency, for fostamatinib for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
  • Knight has previously submitted marketing authorization applications for fostamatinib in Colombia and Mexico.
  • “This submission of fostamatinib demonstrates Knight’s continued execution of our strategy of leveraging our solid platform and expertise to bring innovative therapies for important unmet healthcare needs in Latin America,” said Samira Sakhia, President and Chief Executive Officer of Knight Therapeutics Inc.
    On May 24, 2022, Knight announced that it entered into an agreement with Rigel Pharmaceuticals, Inc. for the exclusive rights to commercialize fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in Latin America.
  • Fostamatinib is commercially available in the United States under the brand name TAVALISSE® and in Europe under the brand name TAVLESSE® for the treatment of adult chronic ITP.

Chevron announces its first solar-to-hydrogen production project in California’s Central Valley

Retrieved on: 
Thursday, February 29, 2024
Environment, Utilities, Oil, Gas, Sustainability, Alternative Energy, Energy, Oxygen, LCI, Greens and Left Alliance, Electrolysis, Aviation, Transport, Hydrogen, Carbon, Lost Hills Oil Field, Electricity, Knight, Water, Renewable energy

Chevron New Energies, a division of Chevron U.S.A. Inc., announced it is developing a 5-megawatt hydrogen production project in California’s Central Valley.

Key Points: 
  • Chevron New Energies, a division of Chevron U.S.A. Inc., announced it is developing a 5-megawatt hydrogen production project in California’s Central Valley.
  • Chevron believes in the value of delivering large-scale hydrogen solutions that support a lower carbon world.
  • “Chevron already offers lower carbon fuels like sustainable aviation fuel, renewable diesel and others, and this project is expected to expand the portfolio of solutions Chevron could supply to the region.
  • “By locating expected production in the Central Valley, we believe the project will be well positioned to meet the demand of customers along an important transportation corridor, as well as having proximity to key California urban markets.”

PPG ranked as leading paints and coatings manufacturer in 2024 Corporate Knights Clean200 list

Retrieved on: 
Wednesday, February 21, 2024
Home Goods, Manufacturing, Environment, Retail, Sustainability, Interior Design, Consumer, Other Construction & Property, Architecture, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Other Retail, Other Manufacturing, Textiles, Packaging, Engineering, Chemicals, Plastics, Corporate Knights, Toxicity, Knight, Carbon, Creativity, Paint, Research, Water, Float glass

PPG (NYSE:PPG) today announced that it was named to the 2024 Corporate Knights Clean200 list as the leading paints, coatings and specialty materials manufacturer.

Key Points: 
  • PPG (NYSE:PPG) today announced that it was named to the 2024 Corporate Knights Clean200 list as the leading paints, coatings and specialty materials manufacturer.
  • The company earned the top spot by having a strong percent of 2022 sales from sustainable products, as defined by Corporate Knights.
  • The Clean200 list ranks the 200 publicly traded companies that have the most sustainable total revenue, earning a minimum of 10% from sustainable sources.
  • 161 overall on the list in sustainable revenue, reporting 19% of sales from products with third party sustainability certifications in 2022.

Swiftly Acquires BYBE, Powering the Future of Alcohol Promotions in Retail

Retrieved on: 
Wednesday, March 6, 2024
Acquisition, Love, Customer success, Partnership, Growth, Entrepreneurship, Business development, Knight

SEATTLE, March 6, 2024 /PRNewswire/ -- Swiftly, a leading provider of innovative technology tools and solutions, today announced its acquisition of the alcohol promotions platform, BYBE. This strategic move combines BYBE's domain expertise in the alcohol category—including its well-established connections with suppliers, retailers, and regulators with Swiftly's current Alcohol Cashback solution. The acquisition will help Swiftly scale its Alcohol Cashback solution and reach more consumers with adult beverage offers and rebates.

Key Points: 
  • SEATTLE, March 6, 2024 /PRNewswire/ -- Swiftly, a leading provider of innovative technology tools and solutions, today announced its acquisition of the alcohol promotions platform, BYBE.
  • This strategic move combines BYBE's domain expertise in the alcohol category—including its well-established connections with suppliers, retailers, and regulators with Swiftly's current Alcohol Cashback solution.
  • The acquisition will help Swiftly scale its Alcohol Cashback solution and reach more consumers with adult beverage offers and rebates.
  • BYBE's Alcohol Cashback platform will be integrated into Swiftly's product suite, simplifying the process for retailers looking to grow their alcohol market share.